Category: COVID
Wuhan Market Samples Contained Covid and Animal Mixtures, Report Says
New York Times In a much-anticipated study, experts described a swab that was positive for the coronavirus and contained loads of genetic material from raccoon dogs. On Jan. 12, 2020, Chinese investigators combing a market for clues about the outbreak of a mysterious new illness in the city of Wuhan swabbed a cart. It was […]
Mar 21, 2023
A Major Clue to COVID’s Origins Is Just Out of Reach
The Atlantic A key set of data could shore up the case for a purely animal origin. So why aren’t scientists sharing it? Last week, the ongoing debate about COVID-19’s origins acquired a new plot twist. A French evolutionary biologist stumbled across a trove of genetic sequences extracted from swabs collected from surfaces at a […]
Mar 21, 2023
Dr. Anthony Fauci Would Like to Set the Record Straight
Rolling Stone Magazine Famed immunologist who led the nation’s COVID response talks new PBS doc, Trump and Fox News, gain-of-function research, the lab-leak theory, and more EVERYONE SEEMS TO have an opinion about Dr. Anthony Fauci. For those on the left, the famed physician and immunologist who led America’s Covid-19 response under presidents Trump and Biden is a […]
Mar 21, 2023
Study finds co-infection with ‘superbug’ bacteria increases SARS-CoV-2 replication
Schulich School of Medicine and Dentistry Global data shows nearly 10 per cent of severe COVID-19 cases involve a secondary bacterial co-infection – with Staphylococcus aureus, also known as Staph A., being the most common organism responsible for co-existing infections with SARS-CoV-2. Researchers at Western have found if you add a ‘superbug’ – methicillin-resistant Staphylococcus […]
Mar 21, 2023
FDA May Authorize Additional Covid-19 Booster Shots
WSJ Agency officials could make the decision on clearing another round for people at high risk within a few weeks. Federal health regulators are nearing a decision on whether to authorize a second round of the Omicron-targeted booster shots for the elderly and other people at high-risk of severe Covid-19, people familiar with the agency’s deliberations said. […]
Mar 21, 2023
Finally, a Potential Therapy to Prevent Long COVID
MedPageToday Diabetes drug found to reduce chance of long COVID in clinical trial preprint. Hi, it’s Jeremy Faust with MedPage Today. Thanks for joining me. Today, we’re going to discuss an interesting new paper called “Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months.” Link to related paper in The Lancet (Preprint) […]
Mar 21, 2023
Long-covid symptoms are less common now than earlier in the pandemic
Washington Post Americans infected with the coronavirus’s omicron variant are less likely to develop symptoms typical of long covid than those who had covid-19 earlier in the pandemic, according to the largest-ever study of who is most vulnerable to being sickened — or debilitated — by the virus’s lingering effects. The analysis of nearly 5 million […]
Mar 21, 2023
The Next Stage of COVID Is Starting Now
The Atlantic What happens when everyone first gets immunity to the coronavirus as a very young kid? To be a newborn in the year 2023—and, almost certainly, every year that follows—means emerging into a world where the coronavirus is ubiquitous. Babies might not meet the virus in the first week or month of life, but […]
Mar 21, 2023
Nirmatrelvir-Ritonavir Effective Against Omicron BA.4, BA.5 SARS-CoV-2 Variant
Pulmonology Advisor Real-world evidence from the Omicron period of the COVID-19 pandemic shows the benefit of nirmatrelvir-ritonavir for vaccinated outpatients and those younger than 65 years of age with non-severe COVID-19 at high risk of hospitalization or death, according to study findings published in The Lancet Infectious Diseases. Investigators sought to examine the real-world effect of […]
Mar 21, 2023
SARS-CoV-2 infection weakens immune-cell response to vaccination
NIH NIH-funded study suggests need to boost CD8+ T cell response after infection. The magnitude and quality of a key immune cell’s response to vaccination with two doses of the Pfizer-BioNTech COVID-19 vaccine were considerably lower in people with prior SARS-CoV-2 infection compared to people without prior infection, a study has found. In addition, the […]
Mar 21, 2023